APLT News and Press, Applied Therapeutics Inc. From 01/05/24

2024-01-05 05:29:04 ET Stock futures inched lower in the early hours of Friday ahead of the December jobs report. Here are some of Friday's biggest stock movers: Biggest stock gainers For further details see: Biggest stock movers today: Peloton, Medical Properties Trust, and...

2024-01-04 18:14:29 ET More on Applied Therapeutics ARISE-HF Phase 3 Trial Likely To Disappoint Due To Multiple Red Flags Applied Therapeutics: Multiple Inflection Points Could Generate Substantial Value Applied Therapeutics: Capital Raise Forthcoming Applied...

AT-001 (caficrestat) demonstrated a strong trend in stabilizing cardiac functional capacity, while the placebo group declined over 15 months AT-001 treatment resulted in a statistically significant difference in cardiac functional capacity in a prespecified subgroup of patients not rece...

2024-01-04 11:37:10 ET Summary Applied Therapeutics has encountered significant valuation challenges since its IPO, primarily due to the limited efficacy of its Aldose Reductase Inhibitors (ARI) franchise. The company is expected to release topline data from ARISE-HF, a phase 3 tr...

2024-01-04 05:19:37 ET Summary EMA validated and accepted the regulatory application of govorestat for the treatment of patients with galactosemia; the FDA has a 60-day review period to look at the application for validation and acceptance. Release of results from the phase 3 ARIS...

2024-01-03 10:55:34 ET More on Applied Therapeutics Applied Therapeutics: Capital Raise Forthcoming Seeking Alpha’s Quant Rating on Applied Therapeutics Historical earnings data for Applied Therapeutics Financial information for Applied Therapeutics ...

NDA submitted to FDA and MAA validated by EMA in December 2023 Submissions are based on positive results from Phase 3 registrational ACTION-Galactosemia Kids study demonstrating consistent long-term clinical outcomes benefit across a range of functional measures and favorable safety profi...

2024-01-02 10:00:09 ET More on Health Care Select Sector SPDR XLV Likely Back To Outperforming XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector Covid-vaccine makers top laggard list, LLY and WST top gainers list Healthcare and uti...

2023-12-07 15:36:49 ET Penny stocks – the cheap stocks trading under $5 per share, offer investors massive upside potential alongside higher risk. Since even incremental price moves translate into huge percentage gains in the stock market, timing entries right can set you up for ...

2023-11-09 08:17:29 ET More on Applied Therapeutics Applied Therapeutics: Capital Raise Forthcoming Applied Therapeutics: Buy For Upcoming Pre-NDA Meeting (I Expect A Positive Outcome) Applied Therapeutics gains after regulatory update on lead asset Seeking A...